Why UNS Energy, Sarepta Therapeutics, and Zale Are Today's 3 Best Stocks
The S&P 500 sinks for a third straight session following a dismal initial weekly jobless claims report, but that didn't stop UNS Energy, Sarepta Therapeutics, or Zale from advancing by double digits.
3 Biggest FDA Decisions of 2013
Sarepta Therapeutics, Ariad Pharmaceuticals, and Amarin saw the FDA backtrack on earlier decisions this year.
3 Black Friday Biotech Bargains
Sarepta Pharmaceuticals, Ariad Pharmaceuticals, and Enanta Pharmaceuticals, which will get royalties from AbbVie, make the list.